Co-Authors
This is a "connection" page, showing publications co-authored by Ankur Kalra and Neil Mehta.
Connection Strength
1.299
-
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e007115.
Score: 0.900
-
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 09 01; 5(9):1020-1026.
Score: 0.225
-
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 02 16; 8(2):165-178.
Score: 0.062
-
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine. 2020 Aug; 58:102907.
Score: 0.056
-
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020 07 01; 3(7):e2014780.
Score: 0.056